This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is true regarding the clinical course of chronic lymphocytic leukemia? a. ... (Read 72 times)

cool

  • Hero Member
  • *****
  • Posts: 570
Which of the following is true regarding the clinical course of chronic lymphocytic leukemia?
 
  a. Aggressive disorder that presents with severe bleeding and anemia
  b. Benign disorder that rarely requires treatment
  c. Mild symptoms but usually fatal within 6 months
  d. Incurable but with a median survival of approximately 10 years

Question 2

What is the preferred specimen to evaluate cellular morphology in the lymphoproliferative disorders?
 
  a. Peripheral blood
  b. Bone marrow
  c. Node frozen sections
  d. Touch imprints of nodes



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

polinasid

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

ANS: D
Chronic lymphocytic leukemia is regarded as an indolent lymphoproliferative disorder. It is currently incurable, and the median survival is up to 10 years.

Answer to Question 2

ANS: D
Touch imprints can be prepared and fixed in formalin or alcohol solution or air-dried for Wright-Giemsa staining to assess cell morphology.





 

Did you know?

Your heart beats over 36 million times a year.

Did you know?

According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.

Did you know?

If you use artificial sweeteners, such as cyclamates, your eyes may be more sensitive to light. Other factors that will make your eyes more sensitive to light include use of antibiotics, oral contraceptives, hypertension medications, diuretics, and antidiabetic medications.

Did you know?

The newest statin drug, rosuvastatin, has been called a superstatin because it appears to reduce LDL cholesterol to a greater degree than the other approved statin drugs.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

For a complete list of videos, visit our video library